|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2001;72:1305
© 2001 The Society of Thoracic Surgeons
a Lenox Hill Hospital, 130 E 77th St, 4th Floor, New York, NY 10021, USA
e-mail: jfonger@heartnet.org
Heart transplantation came into its own over 20 years ago and is now an established therapy for end-stage heart failure. However for the reasons cited in this manuscript some have said you effectively "trade one chronic disease for another after transplantation" given the maintenance requirements these patients must live with to care for their new heart. The preoperative waiting, procurement costs, and subsequent medication expenses make this significantly more expensive than the reparative strategies outlined in this manuscript for treating the failing ventricle.
Twenty years
Related Article
Ann. Thorac. Surg. 2001 72: 1298-1305.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |